Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. They focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation. Their medicines typically address diseases for which there are limited treatment options.
With a presence in approximately 100 countries and regions worldwide, their innovative medicines have reached millions of people in the fight against serious illnesses. Their annual revenue has surpassed $26B.
